**About the Editors**

#### **Jan Korabecny**

Jan Korabecny graduated from the Faculty of Pharmacy (Charles University, Prague, Czech Republic) in 2008. He finished his Ph.D. studies at the Department of Pharmaceutical Chemistry and Drug Control at the same university in 2012. In 2020, he received Associate Professor degree from Pharmaceutical Chemistry at the Faculty of Pharmacy in Hradec Kralove (Charles University). He is currently the head of the Laboratory of Chemistry at the Department of Toxicology and Military Pharmacy, senior researcher and deputy head at the Biomedical Research Centre (University Hospital, Hradec Kralove, Czech Republic) and the head of the Synthesis of Novel Drugs laboratory at National Institute of Mental Health. His area of research is pharmaceutical/medicinal chemistry, biochemistry, and toxicology. His interests are neuroscience, especially the development of novel treatments of Alzheimer's disease based on choliesterase inhibitors, antidotes against organophosphorus poisoning, anticancer agents, and receptor modulators (e.g. NMDA, D2, 5-HT3 etc.). Currently, he is author or co-author of more than 130 scientific publication, with more than 2,300 citation (excluding self-citation) and H-index 30.

#### **Ondrej Soukup**

Ondrej Soukup Tgraduated from the Faculty of Pharmacy (Charles University, Prague, Czech Republic) in 2007. He finished his Ph.D. studies at the University of Defence, Faculty of Military Health Sciences (Hradec Kralove, Czech Republic) in 2011. Currently the head of Biomedical Research Center (University Hospital Hradec Kralove, Czech Republic) and Assoc. Prof. at Department of Toxicology and Military Pharmacy Faculty of Military Health Sciences (University of Defence, Hradec Kralove, Czech Republic). His area of research is pharmaceutical/medicinal chemistry, biochemistry, and toxicology, where he received Associate Professor degree in 2018. His research interests are neuroscience, especially the development of novel treatments for Alzheimer's disease based on choliesterase inhibitors, antidotes against organophosphorus poisoning, disinfectants and receptor modulators (e.g. cholinergic, NMDA, D2, 5-HT3 etc.). Currently, he is author or co-author of more than 150 scientific publication, with more than 2,200 citation (excluding self-citation) and H-index 30.
